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Purpose: Although elevated cardiovascular disease (CVD) risk factors are associated with a 
higher risk of developing heart conditions across all ethnic groups, variations exist between 
groups in the distribution and association of risk factors, and also risk levels. This study assessed 
the 10-year predicted risk in a multiethnic cohort of women and compared the differences in 
risk between Asian and Caucasian women.
Methods: Information on demographics, medical conditions and treatment, smoking behavior, 
dietary behavior, and exercise patterns were collected. Physical measurements were also taken. 
The 10-year risk was calculated using the Framingham model, SCORE (Systematic COronary 
Risk Evaluation) risk chart for low risk and high risk regions, the general CVD, and simplified 
general CVD risk score models in 4,354 females aged 20–69 years with no heart disease, 
diabetes, or stroke at baseline from the third Australian Risk  Factor Prevalence Study. Country 
of birth was used as a surrogate for ethnicity. Nonparametric statistics were used to compare 
risk levels between ethnic groups.
Results: Asian women generally had lower risk of CVD when compared to Caucasian women. 
The 10-year predicted risk was, however, similar between Asian and Australian women, for some 
models. These findings were consistent with Australian CVD prevalence.
Conclusion: In summary, ethnicity needs to be incorporated into CVD risk assessment. 
 Australian standards used to quantify risk and treat women could be applied to Asians in the 
interim. The SCORE risk chart for low-risk regions and Framingham risk score model for inci-
dence are recommended. The inclusion of other relevant risk variables such as obesity, poor diet/
nutrition, and low levels of physical activity may improve risk estimation.
Keywords: cardiovascular disease prevention, risk assessment, epidemiology, Asia, female
Introduction
Globally, cardiovascular disease (CVD) is the leading cause of death, with  approximately 
17 million deaths reported in 2008.1 In absolute numbers, more CVD deaths occurred 
in women than men.2 CVD risk can be quantified by risk score models using multiple 
variables and their interactions. This is a cost effective approach to identify high-risk 
individuals for preventive treatment, especially in Asian countries experiencing large 
increases in CVD incidence.3
Modifiable risk factors associated with CVD and other noncommunicable diseases 
are becoming more prevalent.4–6 Although elevated CVD risk factors increase the risk 
of developing CVD across all ethnic groups,7,8 there is emerging evidence of variation 
in the distribution of modifiable risk factors between ethnic groups which may explain 
the differences in CVD risk.9–13





The prevalence of risk factors differs across ethnic groups. 
The rate of hypertension is approximately two times higher 
in South Asians when compared to the general population of 
London.14 In the Asia Pacific Cohort Studies Collaboration 
study, systolic blood pressure (SBP) and total cholesterol 
were more strongly associated with CVD risk in Asian than in 
Caucasian women.3 Diabetes is also more prevalent in Asian 
populations consisting of Chinese, Indians, and Japanese 
when compared to Caucasians.8 The prevalence of diabetes 
is about 3–5 times higher in South Asians when compared 
to Europeans12,14,15 and should be included in screening 
and surveys, particularly, in the prediction of CVD risk in 
Asians.15
The effect of risk factors on CVD risk also differs in 
Caucasian and Asian women, thus explaining the need for 
separate cutoff values. For example, when assessing abdomi-
nal obesity, a waist circumference (WC) of $88 cm would 
increase a Caucasian woman’s risk of diabetes and CVD 
while a lower cutoff value of WC $80 cm would place an 
Asian woman at increased risk.9 It should also be noted that 
results differ depending on which anthropometric measure-
ment is used for assessing adiposity. Bangladeshi women 
reported a lower prevalence of overweight and obesity 
(body mass index [BMI] .25 kg/m2) using BMI but a higher 
prevalence of raised waist-to-hip ratio (WHR) and WC when 
compared to the general population of England.16
Due to differences in distribution and association of 
 certain risk factors with CVD, and differing CVD risk 
between Asian and Caucasian women, the British Cardiac 
Society, British Hypertension Society, Diabetes UK, HEART 
UK, Primary Care Cardiovascular Society, and the Stroke 
Association have all emphasized the importance of incorpo-
rating ethnicity into CVD risk assessment.9 The  inclusion of 
ethnicity along with other variables also improved the accu-
racy of a risk score model in identifying those at high-risk of 
CVD.17 Existing risk score models are primarily developed 
and validated in Caucasians and most models have not 
incorporated ethnicity as a risk variable.18
This study therefore aims to predict the 10-year coronary 
heart disease (CHD) and CVD incidence and/or mortality 
risk in a multiethnic cohort of 4,354 disease free women at 
baseline, and to compare the differences in risk between Asian 
and Caucasian women. Five established models for predicting 
CVD risk are utilized: Framingham model, SCORE (System-
atic COronary Risk Evaluation) model for low-risk regions 
(which was developed from European countries with low 
CVD rates, ie, Belgium, Italy, and Spain), SCORE model for 
high-risk regions (European countries with high CVD rates, 
ie, Denmark, Finland, and Norway), general CVD risk score 
model, and simplified general CVD risk score model.
Methods
study cohort
The study cohort consisted of a representative sample of 
4,354 females aged 20–69 years with no previous history of 
heart disease, diabetes, or stroke at baseline from the third 
Risk Factor Prevalence Study,19 conducted by the National 
Heart  Foundation of Australia in 1989. The subjects consisted 
of residents on the federal electoral rolls in December 1988 
in north and south Sydney, Melbourne, Brisbane, Adelaide, 
Perth, Hobart, Darwin, and Canberra in a systematic 
 probability sampling by sex and 5-year age groups. Country 
of birth was used as a surrogate for ethnicity and grouped into 
regions as described by the Australian Risk Factor Prevalence 
Study Management Committee.19
ethics
Ethical approval for the survey was obtained in advance 
from the Australian Institute of Health Interim Ethics 
 Committee, after consultation with the Commonwealth 
Privacy  Commissioner. The present study was approved by 
the Human Research Ethics Committee at Curtin University, 
and complies with the Declaration of Helsinki.
Data and measurements
A self-administered questionnaire was completed and 
 information on demographic and socioeconomic characteris-
tics, medical conditions and treatment, oral contraceptive use, 
alcohol consumption, smoking behavior, dietary behavior, 
and exercise patterns were collected. The following physical 
measurements were taken: height (to the nearest centimeter), 
weight (to the nearest tenth of a kilogram), waist and hip cir-
cumference, systolic and diastolic blood pressure, and lipid 
levels. Waist and hip circumference were measured accord-
ing to standardized methodologies20,21 using two observers. 
The mean of two measurements was taken at each site to 
the nearest centimeter. Blood pressure levels were recorded 
from the right arm of subjects at rest, each 5 minutes apart, 
using mercury sphygmomanometers. Fasting blood samples 
were collected in ethylenediaminetetraacetic acid tubes 
and separated within 3 hours and stored at 4°C until they 
were dispatched to the central laboratory at the Division of 
 Clinical Chemistry, Institute of Medical and Veterinary Sci-
ence, Adelaide, Australia each week to be assayed for plasma 
cholesterol, high density lipoprotein (HDL) cholesterol, and 
triglyceride levels.




assessing cardiovascular disease risk for asians
risk score models
The Framingham risk score model published by 
Anderson et al,22 SCORE risk chart for low-risk and high-
risk regions,23 and general CVD or simplified general CVD 
risk score models24 were used to calculate the 10-year risk of 
CHD and CVD incidence and/or mortality. Both Framingham 
and general CVD risk score models were developed based on 
data from the American Framingham Heart Study, but with 
significant differences.22,24 Participants aged 30–74 years who 
were free of CVD and cancer were included in developing 
the Framingham model22 while only individuals without 
CVD were used in the development of the general CVD 
risk score model.24 The general CVD risk score model was 
developed using data from a larger cohort compared to the 
Framingham model.
The SCORE risk chart for low-risk and high-risk regions 
was developed by pooling 12 cohort studies to predict the 
10-year CHD and CVD mortality risk in Europe. The cohorts 
consisted of participants aged 19–80 years.23 Those with a 
previous history of heart attack were not included in model 
development.23 The SCORE model was derived from a 
much larger dataset than the general CVD and Framingham 
risk score models. The risk chart for high-risk regions was 
derived from cohorts in Denmark, Finland, and Norway as 
they had higher CVD rates, controlling for risk factor levels, 
age,25 cohort sizes, and data availability.23 The risk chart for 
low-risk regions was developed using cohorts in Belgium, 
Italy, and Spain.23
The Weibull distribution and Cox proportional hazards 
regression were used to determine significant risk vari-
ables for inclusion in the Framingham and SCORE, and 
general CVD or simplified general CVD risk score model, 
 respectively. Similar outcomes were predicted by these 
models except the SCORE model which predicted only fatal 
CHD and CVD events. The Framingham model defined CHD 
and CVD mortality based on death certificates in more than 
50% of cases while morbidity follow-up was sophisticated 
and difficult to reproduce,26,27 and SCORE defined mortality 
using International Classification of  Diseases (ICD)-9 codes 
which were based on death certificates as well.28 CHD and 
CVD incidence and mortality were adjudicated using medi-
cal histories, physical examinations, hospitalization records, 
and communication with physicians for the general CVD 
or simplified general CVD risk score model.24 All models 
included age, sex, SBP, and smoking status. The simpli-
fied general CVD risk score model also included BMI (as 
an alternative to total and HDL cholesterol levels), use of 
antihypertensive medication, and diabetes. Diabetes was 
also incorporated into the Framingham model but not the 
SCORE model.
Data analysis
Demographic and clinical characteristics of the sample were 
described using mean ± standard deviation and median 
(interquartile range) for continuous variables, while counts 
(percentages) and odds ratios (95% confidence interval) were 
used for categorical variables. Differences in categorical risk 
factors were assessed using logistic regression, with age as 
a covariate.
The 10-year CHD and CVD incidence and/or mortal-
ity risk was calculated using published Weibull or Cox 
proportional hazards regression model for each subject, 
for Framingham, SCORE for low-risk regions, SCORE 
for  high-risk regions, general CVD, and simplified general 
CVD risk score models. Medians and interquartile range 
were presented and nonparametric tests were utilized as the 
distribution of risk within each ethnic group was skewed. 
 Comparisons of risks between ethnic groups were assessed 
using Kruskal–Wallis test and Mann–Whitney U test. The 
10-year risks were expressed as percentages for ease of 
reporting. All statistical analyses were performed with 
IBM SPSS Statistics version 20 (IBM Corporation, Armonk, 
NY, USA). P-values of less than 0.05 were considered to be 
statistically significant.
Results
Table 1 presents the distribution of CVD risk variables in 
4,354 women without heart disease, diabetes, or stroke at 
baseline, according to ethnicity. Generally, lower proportions 
of Asian women were identified to be above the cut points for 
individual risk factors recommended for use in the clinical 
diagnosis of the metabolic syndrome29–33 and increased risk 
of CVD34–41 when compared to Caucasian women. A higher 
proportion of southern European women were generally 
above the cut points compared to all other ethnic groups. 
Generally, the largest difference across all risk factors was 
between southern European and Asian women, and  Australian 
and Asian women were most similar.
The 10-year predicted CVD and CHD incidence and/or 
mortality risks were compared between ethnic groups and 
are presented in Tables 2 and 3, respectively. Women from 
the UK and Ireland, northern Europe, and southern Europe 
had higher risk and were significantly different from Asian 
women (P,0.0005) after calculations from all five mod-
els for CVD and CHD mortality, incidence and mortality, 
and incidence. Southern European women reported the 





highest risk among all ethnicities for both CVD and CHD. 
 Australian women were not significantly different (P.0.05) 
to Asian women in the predicted CVD and CHD mortality 
risk, using the SCORE risk chart for low- and high-risk 
regions (Tables 2 and 3). Australian women were also not 
significantly different from Asian women (P.0.05) in the 
predicted CHD mortality and CHD incidence risk, using 
the Framingham model (Table 3). Differences in risk levels 
between southern European and Asian women were the 
largest while Australian and Asian women were the least 
different.
Table 4 presents the prevalence of CVD in Australia 
among adults (age $18 years), according to ethnicity. 
 Australians and Asians reported similar proportions of 
people with CVD. The proportion of people with CVD 
decreased between 2007–2008 and 2011–2012 across all 
Caucasian ethnic groups while the proportion of Asians 
with CVD increased. In 2011–2012, the prevalence of CVD 
among Australians was 3.2% compared to 2.9% for Asians. 
The least difference in the prevalence of CVD was therefore 
between Australians and Asians and the largest difference 
was between southern Europeans and Asians.
Discussion
In this study, fewer Asian women were above the cut points 
for the clinical diagnosis of the metabolic syndrome and 
increased CVD risk than Caucasian women. Generally, they 
had significantly lower CHD and CVD risk when compared 
to Caucasian women. Ethnic variation in the 10-year CHD 
and CVD risk were also evident in some previous studies.46,47 
In Norway, a study used the SCORE model for high-risk 
regions to assess participants free of myocardial infarction, 
stroke, angina pectoris, diabetes, and who had no prior use 
of antihypertensive medication.46 Norwegian women reported 
higher 10-year predicted CVD mortality risk, 40% higher 
than the risk of Asian (Pakistan, Sri Lanka, and Vietnam) 
women.46 Similar results were also observed in another 
Norwegian study using the general CVD risk score model.47 
Research studies generally recommend using a lower treat-
ment threshold for Asians, considering their lower risk levels, 
but this requires testing.48,49
The CVD risk in our study was, however, similar between 
Australian and Asian women from the SCORE risk chart 
and Framingham models. Thus, it would also be expected 
that Australians and Asians report similar CVD prevalence, 
Table 1 characteristics of the cohort of 4,354 women without heart disease, diabetes, or stroke by ethnicity







count n 3,329 416 180 234 195
age (years) Mean ± sD 41.9±13.5 45.7±12.5 49.0±11.7 47.8±10.6 40.5±10.9
Weight (kg) Mean ± sD 65.4±12.6 65.2±12.0 66.5±12.6 66.9±11.8 58.6±11.6
Height (cm) Mean ± sD 162.8±6.0 162.3±6.2 161.9±6.2 156.8±6.1 156.7±5.7
BMI ($30 kg/m2) n (%) 403 (12.2%) 49 (11.8%) 29 (16.2%) 45 (19.7%) 18 (9.3%)
Or (95% cI) 1.29 (0.78, 2.12) 1.12 (0.63, 1.99) 1.49 (0.79, 2.80) 1.96 (1.09, 3.54) ref
Wc ($80 cm) n (%) 988 (29.8%) 134 (32.2%) 62 (34.4%) 123 (52.8%) 47 (24.2%)
Or (95% cI) 1.22 (0.87, 1.73) 1.17 (0.78, 1.74) 1.12 (0.70, 1.78) 2.65 (1.72, 4.07) ref
WHr ($0.8) n (%) 732 (22.0%) 102 (24.6%) 49 (27.2%) 98 (42.1%) 44 (22.7%)
Or (95% cI) 0.86 (0.60, 1.23) 0.85 (0.56, 1.29) 0.85 (0.52, 1.38) 1.83 (1.18, 2.83) ref
Wsr ($0.5) n (%) 895 (27.1%) 116 (28.0%) 61 (33.9%) 131 (56.7%) 50 (25.9%)
Or (95% cI) 0.95 (0.68, 1.34) 0.83 (0.55, 1.24) 0.95 (0.60, 1.51) 2.78 (1.81, 4.26) ref
sBP ($130 mmHg) n (%) 923 (27.7%) 135 (32.5%) 65 (36.1%) 93 (39.7%) 39 (20.0%)
Or (95% cI) 1.29 (0.86, 1.93) 1.19 (0.75, 1.88) 1.06 (0.63, 1.81) 1.50 (0.92, 2.45) ref
DBP ($85 mmHg) n (%) 645 (19.4%) 81 (19.5%) 48 (26.7%) 71 (30.3%) 23 (11.9%)
Or (95% cI) 1.56 (0.98, 2.47) 1.25 (0.75, 2.11) 1.61 (0.91, 2.86) 2.18 (1.28, 3.74) ref
HDl ($1.3 mmol/l) n (%) 2,259 (69.3%) 287 (70.2%) 119 (70.0%) 144 (62.9%) 122 (65.6%)
Or (95% cI) 1.18 (0.86, 1.61) 1.20 (0.83, 1.73) 1.16 (0.74, 1.82) 0.85 (0.57, 1.28) ref
Tc ($5.5 mmol/l) n (%) 1,431 (43.9%) 214 (52.3%) 91 (53.5%) 130 (56.8%) 66 (35.5%)
Or (95% cI) 1.37 (0.99, 1.90) 1.57 (1.07, 2.29) 1.31 (0.83, 2.06) 1.66 (1.09, 2.52) ref
Triglycerides 
($1.7 mmol/l)
n (%) 390 (12.0%) 61 (14.9%) 29 (17.1%) 37 (16.2%) 31 (16.7%)
Or (95% cI) 0.60 (0.40, 0.91) 0.68 (0.42, 1.10) 0.69 (0.39, 1.21) 0.70 (0.41, 1.19) ref
current smoker (Yes) n (%) 751 (22.6%) 91 (21.9%) 39 (21.7%) 32 (13.7%) 19 (9.7%)
Or (95% cI) 2.78 (1.72, 4.50) 2.91 (1.71, 4.94) 3.09 (1.70, 5.61) 1.72 (0.94, 3.16) ref
Notes: Odds ratio and associated 95% confidence intervals were calculated using logistic regression after adjusting for age.
Abbreviations: BMI, body mass index; CI, confidence interval; DBP, diastolic blood pressure; HDL, high density lipoprotein; OR, odds ratio; SBP, systolic blood pressure; 
Tc, total cholesterol; Wc, waist circumference; WHr, waist-to-hip ratio; Wsr, waist-to-stature ratio; n, number; ref, reference group.




assessing cardiovascular disease risk for asians
considering they had similar risk, and this was borne out in 
the comparisons of CVD prevalence from the Australian 
Bureau of Statistics.42–45 This is supported by an existing 
study using the general CVD risk model. Except for southeast 
Asians, most Asian women were not statistically significantly 
different from Norwegian women in their 10-year CVD risk 
calculated from the general CVD risk model.47
Risk score models that incorporated the prediction of inci-
dent events were expected to report higher risk score values 
when compared to those that only predicted CHD or CVD 
mortality, with an increase in sensitivity and the identifica-
tion of more subjects for treatment. The  Framingham risk 
score model for predicting CHD or CVD incidence and the 
general CVD or simplified general CVD model for predicting 
CHD or CVD incidence and mortality reported higher risk 
score values. In applying risk prediction to Asian women, the 
model should be able to predict stroke as well, considering 
Asian countries generally report higher stroke mortality than 
Western countries.8
Certain models better predict the risk in Asian women. 
One study reported that the SCORE model based on total 
cholesterol/HDL cholesterol ratio may be more applicable 
to Asian (Pakistan, Sri Lanka, and Vietnam) women when 
compared to the SCORE total cholesterol model, but this can 
only be confirmed using mortality outcome data.46 The choice 
of risk score model does have an impact on risk estimation 
and risk categorization.50
None of the models included in this study incorporated 
ethnicity into their risk assessment. While these models 
had been evaluated in different ethnic groups, including in 
Asians, ethnic differences in risk prediction have not been 
previously analyzed. To date, only the QRISK score model 
included self-assigned ethnicity as a risk variable.17 Some 
of the risk variables in the QRISK model such as Townsend 
deprivation score17 could not be collected in our study. A web 
based risk calculator (ETHRISK) to predict the 10-year 
CHD and CVD risk is also available.51 It was developed by 
recalibrating the Framingham risk score model to predict 
the risk in seven British black and minority ethnic groups.51 
It should be noted that diabetes, an important risk variable 
for predicting CVD risk in Asian women, was not included 
in this calculator.51
Table 2 Predicted 10-year cardiovascular disease incidence and/or mortality risk (%) in 4,354 women without heart disease, diabetes, 
or stroke by ethnicity
Australia United Kingdom 
and Ireland
Northern Europe Southern Europe Asia
Cardiovascular disease mortality
Framingham risk score model
  Median (%) 
(25th, 75th percentile)
0.08 (0.02, 0.49) 0.14 (0.03, 0.83) 0.21 (0.05, 1.41) 0.31 (0.05, 1.01) 0.04 (0.01, 0.18)
 P-value ,0.0005 ,0.0005 ,0.0005 ,0.0005 ref
scOre risk chart for low-risk regions
  Median (%) 
(25th, 75th percentile)
0.05 (0, 0.50) 0.15 (0.02, 0.75) 0.21 (0.05, 1.66) 0.27 (0.05, 0.97) 0.03 (0.01, 0.23)
 P-value 0.176 ,0.0005 ,0.0005 ,0.0005 ref
scOre risk chart for high-risk regions
  Median (%) 
(25th, 75th percentile)
0.08 (0.01, 0.78) 0.24 (0.04, 1.21) 0.34 (0.08, 2.43) 0.43 (0.08, 1.49) 0.05 (0.01, 0.35)
 P-value 0.167 ,0.0005 ,0.0005 ,0.0005 ref
Cardiovascular disease incidence and mortality
general cardiovascular disease risk score model
  Median (%) 
(25th, 75th percentile)
2.26 (1.05, 6.08) 3.57 (1.55, 7.89) 4.05 (2.14, 10.11) 4.98 (2.07, 8.24) 1.77 (0.94, 4.06)
 P-value 0.005 ,0.0005 ,0.0005 ,0.0005 ref
Simplified general cardiovascular disease risk score model
  Median (%) 
(25th, 75th percentile)
2.32 (0.99, 6.25) 3.50 (1.42, 7.55) 4.14 (2.04, 9.54) 4.76 (2.17, 8.49) 1.72 (0.87, 3.83)
 P-value 0.001 ,0.0005 ,0.0005 ,0.0005 ref
Cardiovascular disease incidence
Framingham risk score model
  Median (%) 
(25th, 75th percentile)
3.95 (1.19, 12.79) 6.96 (2.30, 16.81) 8.38 (3.79, 19.34) 10.19 (3.65, 17.17) 2.79 (0.95, 8.25)
 P-value 0.010 ,0.0005 ,0.0005 ,0.0005 ref
Abbreviations: scOre, systematic cOronary risk evaluation; ref, reference group.





Other relevant risk factors associated with CHD and CVD 
risk18,52 such as obesity, low levels of physical activity, poor 
diet/nutrition, alcohol consumption, use of antihypertensive 
medication, chronic kidney disease, and coronary artery 
calcium have not been incorporated into some of these 
models. Only BMI was included in the simplified general 
CVD risk score model. Limitation of BMI includes that it 
does not account for the variability in body fat distribution 
across different ethnic groups. For example, the Chinese 
and south Asians deposit more abdominal adipose tissue 
when compared to Europeans.53 In a study conducted on 
Sri Lankan adults, BMI was not a significant predictor of 
CHD risk in females while WC independently predicted 
CHD risk in females.54 Anthropometric measurements such 
as WC, WHR, and waist-to-stature ratio (WSR) have not 
been included in any of these models although they have 
been shown to be better predictors of obesity and CHD 
and CVD risk.38,55–57 A study reported that the WHR is a 
stronger predictor of CHD and CVD risk when compared 
to BMI and thus it is preferred for clinical use.37 Another 
study also supported the use of WHR for assessing obesity 
as it has low measurement error, high precision, and no bias 
across a wide range of ethnic groups.58 A recent systematic 
review and meta-analysis comprising of more than 300,000 
adults from different ethnic groups was conducted to assess 
the screening potential of WSR, WC, and BMI.59 The WSR 
performed better in terms of its discriminatory power when 
compared to WC and BMI in differentiating those with 
Table 3 Predicted 10-year cHD incidence and/or mortality risk (%) in 4,354 women without heart disease, diabetes, or stroke by 
ethnicity
Australia United Kingdom  
and Ireland
Northern Europe Southern Europe Asia
Coronary heart disease mortality
Framingham risk score model
  Median (%) 
(25th, 75th percentile)
0.01 (0, 0.19) 0.03 (0, 0.42) 0.07 (0, 0.73) 0.13 (0.01, 0.52) 0 (0, 0.07)
 P-value 0.081 ,0.0005 ,0.0005 ,0.0005 ref
scOre risk chart for low-risk regions
  Median (%) 
(25th, 75th percentile)
0.02 (0, 0.27) 0.08 (0.01, 0.41) 0.12 (0.02, 0.84) 0.14 (0.03, 0.49) 0.02 (0, 0.11)
 P-value 0.161 ,0.0005 ,0.0005 ,0.0005 ref
scOre risk chart for high-risk regions
  Median (%) 
(25th, 75th percentile)
0.05 (0, 0.49) 0.15 (0.02, 0.75) 0.21 (0.05, 1.48) 0.26 (0.05, 0.89) 0.03 (0.01, 0.20)
 P-value 0.156 ,0.0005 ,0.0005 ,0.0005 ref
Coronary heart disease incidence and mortality
general cardiovascular disease risk score model
  Median (%) 
(25th, 75th percentile)
1.38 (0.64, 3.70) 2.17 (0.94, 4.80) 2.47 (1.30, 6.15) 3.03 (1.26, 5.02) 1.08 (0.57, 2.47)
 P-value 0.005 ,0.0005 ,0.0005 ,0.0005 ref
Simplified general cardiovascular disease risk score model
  Median (%) 
(25th, 75th percentile)
1.41 (0.61, 3.80) 2.13 (0.86, 4.59) 2.52 (1.24, 5.81) 2.90 (1.32, 5.17) 1.05 (0.53, 2.33)
 P-value 0.001 ,0.0005 ,0.0005 ,0.0005 ref
Coronary heart disease incidence
Framingham risk score model
  Median (%) 
(25th, 75th percentile)
1.99 (0.17, 8.33) 4.45 (0.87, 11.00) 5.20 (1.99, 11.90) 7.01 (2.04, 11.89) 1.52 (0.22, 6.15)
 P-value 0.317 ,0.0005 ,0.0005 ,0.0005 ref
Abbreviations: cHD, coronary heart disease; scOre, systematic cOronary risk evaluation; ref, reference group.
Table 4 cardiovascular disease prevalence in adults (age $18 years) by ethnicity
Australia United Kingdom Northern Europe Southern Europe Asia
aBs (2011–2012)42,43 3.2% 6.1% 5.8% 7.7% 2.9%
aBs (2007–2008)44 3.7% 6.5% 8.2% 9.9% 2.4%
aBs (2004–2005)45 2.6% 5.8% 6.5% 4.9% 2.2%
Abbreviation: aBs, australian Bureau of statistics.
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diabetes,  hypertension, CVD, and all outcomes in females.59 
Conversely, the role of obesity may be mediated through 
total cholesterol, HDL cholesterol, elevated blood pressure, 
and diabetes and thus was not  considered as a risk variable 
that would affect CVD treatment in the National Cholesterol 
Education Program’s Third Adult Treatment Panel (ATP-III) 
guidelines.60 More studies are needed to ascertain the role 
of obesity in CVD risk assessment and the most valid and 
appropriate measurement(s) for assessing adiposity in women 
of different ethnicity.
Conclusion
In conclusion, ethnicity influences the distribution of CVD 
risk factors and the 10-year predicted CHD and CVD risk, 
with Asian women generally reporting lower risk when 
compared to Caucasian women across all models assessed 
in this study. This implies a lower treatment threshold may 
be appropriate for Asian women but further research is 
required.
In the interim, Australian standards for the quantifica-
tion of CVD risk and treatment related decisions in women 
based on calculated risk should include Asians in Australia. 
The SCORE risk chart for low-risk regions for the calcu-
lation of 10-year CHD and CVD mortality risk and the 
Framingham risk score model for the 10-year prediction 
of CHD incidence are recommended. More multiethnic 
cohort studies are needed to establish this recommenda-
tion to more accurately identify appropriate individuals for 
preventive treatment.
Ethnicity should be incorporated into existing and future 
risk score models. Alternatively, risk score models can be 
recalibrated prior to use in different populations, such as 
Asians, which has been done in some studies.  Recalibration 
ensures the transferability of risk score models across 
ethnic groups.61
Risk score models should incorporate important risk 
 factors such as diabetes, SBP, and total cholesterol level when 
predicting the CVD risk of Asian women. The inclusion of 
other relevant risk variables such as obesity, low levels of 
physical activity, poor diet/nutrition, alcohol consumption, 
use of antihypertensive medication, chronic kidney disease, 
and coronary artery calcium may improve risk estimation. 
Finally, more accurate and appropriate measures of  adiposity 
(other than BMI) to assess body fat distribution among Asians 
also needs further evaluation.62
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